Clinical trial
Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms
NCT03345329 is registered in ClinicalTrials.gov with General Biologicals Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms
- Lead sponsor
- General Biologicals Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2015
- Completion date
- September 30, 2016
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.